- July 17, 2026
Women’s Health Research at Yale Funds Projects on Obesity and Ovarian Aging, Diabetes, Cancers, and Autoimmunity
- June 03, 2026
New AI tool maps hidden geography of gene activity
- May 27, 2026Source: Miami Herald
45% of the nation’s tap water contains chemicals that may be harmful to humans, experts warn
- March 31, 2026
What experts wish you knew about colon cancer
Cancer
More people today die from cancer than from almost any other cause in the world. The challenges posed by cancer are immense and top scientists at the Yale School of Public Health are committed to reducing its toll.
The departments of Chronic Disease Epidemiology, Biostatistics and Health Policy and Management are heavily focused on a wide variety of cancer-related research, and the Department of Environmental Health Sciences is renowned for novel approaches to the study of how environmental exposures affect health outcomes. From key partnerships with the Yale Cancer Center to collaborative efforts locally and globally, YSPH scientists are taking significant steps toward preventing and treating a wide range of cancers. Today, research in cancer and other chronic diseases encompasses interdisciplinary teams committed to understanding cancer causation and etiology, prevention, screening and early detection, risk factors, environmental exposures, social determinants of health and survival.
A variety of technologies and approaches are used to detect mechanisms and characteristics of the many different types of cancer, including genomics, metabolomics, social and behavioral effects, evolutionary biology, biostatistical methodology and study design, and outcomes research.
The Yale School of Public Health maintains biospecimens and data from thousands of individuals in more than a dozen studies that can be made applied to future research. It also has partnerships with numerous international cancer researchers, and is the home of leading experts in clinical trial design and data management, and genomic and metabolic centers.
Recent Publications
Copy Link
- Individualized Treatment Effect Inference of Head and Neck Cancer with Multimodal Data.Wei Y, Li Z, Woo J, Ouyang J, El Fakhri G, Liu X. APSIPA Trans Signal Inf Process. 2026 Dec 14; 2026 May 1. PMID: 42125301.
- Migration-Associated Variation in Gastric Cancer Risk in the United States: Implications for Risk Stratification.Hyun CS, Wang R, Hong SH, Zhang X, Shin JI. Int J Cancer. 2026 Oct 15; 2026 Jun 7. PMID: 42252557.
- Risk of second primary malignancies in older long-term survivors of breast, prostate, colon, and rectal cancer.Kwaramba T, Westvold S, Long JB, Hyslop T, Silber A, Yasin F, Forman R, Taylor M, Wang SY, Leapman M, Leeds IL, Cecchini M, Spees LP, Wheeler SB, Gross CP, Oeffinger K, Dinan MA. J Natl Cancer Inst. 2026 Oct 13; 2026 Oct 13. PMID: 42867138.
- Neonatal Dried Blood Spot Metabolomics Reveals Signatures of Early-Onset Myeloproliferative Neoplasms.Berardi D, Johnson CH, DeWan AT, Wang R, Jain A, Wiemels JL, Metayer C, Podoltsev NA, Ma X. Int J Cancer. 2026 Oct 9; 2026 Oct 9. PMID: 42853680.
- Dietary intake of vitamins B1, B2, B3, and B6, and the risk of gastric cancer: pooled analyses within the Stomach cancer Pooling (Stop) project.Collatuzzo G, Pelucchi C, Sassano M, Bonzi R, Vioque J, Gonzales-Palacios S, Seyyedsalehi MS, Lunet N, Morais S, Castaño-Vinyals G, Larrea-Baz NF, Ferraroni M, Zaridze D, Maximovich D, Yu GP, Zhang ZF, Lopez-Carrillo L, Ward MH, Lopez-Cervantes M, Hernandez-Ramirez RU, Rabkin CS, Malekzadeh R, Pakseresht M, Tsugane S, Hidaka A, Camargo MC, Curado MP, Bravi F, Negri E, La Vecchia C, Boffetta P. Eur J Nutr. 2026 Oct 7; 2026 Oct 7. PMID: 42841975.
- Gaps in Gastric Cancer Risk Awareness Despite High Preventive Engagement among Korean-Born Adults in the United States.Hyun CS, Roh A, Lee YJ, Kim SS. J Cancer Educ. 2026 Oct 5; 2026 Oct 5. PMID: 42832152.
- Cancer evolution in its native host: oncogenic selection and epistasis revealed by human tumor genomes.Liu M, Dasari K, Alfaro-Murillo JA, Townsend JP. J Evol Biol. 2026 Oct 1; 2026 Oct 1. PMID: 42820733.
- Comparison and interpretability of machine learning algorithms to predict survival of patients with prostate cancer.Kim IE, Meier-Scherling CPG, Zhou SR, Soerensen SJC, Ajjawi I, Chung BI, Shkolyar E, Sonn GA, Liao JC, Leapman MS. Urol Oncol. 2026 Oct; 2026 Aug 31. PMID: 42674923.
- The Childhood Cancer and Leukemia International Consortium (CLIC): Expanding global collaboration in pediatric cancer etiology research.Mora AM, Mejía-Arangure JM, Dockerty JD, Rashed WM, Núñez-Enríquez JC, Auvinen A, Bailey H, Bonaventure A, Lee PC, Chow EJ, Clavel J, Crowe J, de Smith AJ, Dolatkhah R, Erdmann F, Filippini T, Force LM, Hansen J, Heck JE, Infante-Rivard C, Kane E, Kang AY, Kantzanou M, Lohi O, Lupo PJ, Ma X, Magnani C, Marcotte EL, Metayer C, Nikkilä A, Ntzani E, Olsson A, Petridou ET, Pombo-de-Oliveira MS, Psaltopoulou T, Ribeiro KB, Roman E, Scott R, Sergentanis TN, Scheurer ME, Schraw JM, Schüz J, Vinceti M, Wiemels J, Wünsch-Filho V, Yang T, Mueller BA, Spector LG. Cancer Epidemiol. 2026 Oct; 2026 Aug 21. PMID: 42628293.
- Projected lives saved and economic value of mRNA cancer immunotherapies in the United States.Wells CR, Pandey A, Bawden C, Ye Y, Bilori B, Potter-Schwartz L, Ayaz L, Moghadas SM, Townsend JP, Fitzpatrick MC, Galvani AP. Lancet Reg Health Am. 2026 Oct; 2026 Aug 8. PMID: 42604060.
- Differences in overall survival for invasive epithelial ovarian cancer by race and ethnicity: results from the Ovarian Cancer Association Consortium.Meagher NS, White KK, Wilkens LR, Anton-Culver H, Bandera EV, Carney ME, Cramer DW, Cushing-Haugen KL, DeFazio A, Doherty JA, Gentry-Maharaj A, Goode EL, Goodman MT, Harris HR, Karlan BY, Kaufmann SH, Kelemen LE, Köbel M, Koziak JM, Le Marchand L, Lester J, McGuire V, Menon U, Modugno F, Moysich KB, Pearce CL, Pharoah PDP, Pike MC, Qin B, Risch HA, Rothstein JH, Sarink D, Sieh W, Steed H, Terry KL, Thompson PJ, Titus LJ, Van Gorp T, Whittemore AS, Winham SJ, Jordan SJ, Wu AH, Webb PM, Peres LC, Merritt MA. Br J Cancer. 2026 Oct; 2026 Jun 30. PMID: 42373846.
- Clinical Instruments Assessing Harms and Benefits of Long-Term Opioid Therapy for Chronic Pain: A Scoping Review.Grant AD, Ali M, Cheng A, Funaro MC, Black AC, Esserman D, DeBar LL, Edmond S, Becker WC. J Gen Intern Med. 2026 Oct; 2026 Jun 1. PMID: 42225871.
- Evidence supporting European Medicines Agency drug approvals (2020-2023): A cross-sectional study of trial design and outcomes.Siebert M, Caquelin L, Naudet F, Ross JS, Ramachandran R. Clin Trials. 2026 Oct; 2026 Apr 7. PMID: 41944409.
- AREA-LEVEL SOCIAL AND STRUCTURAL DETERMINANTS OF HEALTH AND CERVICAL CANCER STAGE AT DIAGNOSIS.Girgis AM, Radillo K, Irwin M, Sheth SS, Niccolai LM. Am J Prev Med. 2026 Sep 23; 2026 Sep 23. PMID: 42777973.
- UV signature mutation hyperhotspots as genomic dosimeters.Menon V, García-Ruiz A, Neveu S, Cartmel B, Ferrucci LM, Palmatier M, Ko C, Tsai KY, Nakamura M, Kim SR, Girardi M, Kornacker K, Brash DE. Photochem Photobiol. 2026 Sep 22; 2026 Sep 22. PMID: 42773615.
- Correction: Protocol for a Sequential Multiple Assignment Randomized Trial to Improve Physical Activity and Diet Quality in Survivors of Cancer.Chow EJ, Lee ED, Hershberger M, Jenssen K, Di C, Doody DR, Hogue B, Mendoza JA, Muller TM, Schenk JM, Syrjala KL, Xu Y, Yi J, Zhao YQ, Armstrong GT, Neuhouser ML, Oeffinger KC. JMIR Res Protoc. 2026 Sep 21; 2026 Sep 21. PMID: 42766795.
- Steatotic Liver Disease Risk Scores to Predict Cirrhosis and Hepatocellular Carcinoma.Mezzacappa C, Tate JP, Torgersen J, Skanderson M, Taddei TH, Justice AC. JAMA Intern Med. 2026 Sep 21; 2026 Sep 21. PMID: 42766290.
- Identifying shared polygenic risk across cancers.Hu J, Muheyati M, Xu L, DeWan A, Zhao H. PLoS Genet. 2026 Sep; 2026 Sep 18. PMID: 42758802.
- Implementation of Community-Based Helicobacter pylori Screening and Navigation in High-Risk Immigrant Communities.Hyun CS, Roh A, Lee YJ, Kim SS. Health Promot Pract. 2026 Sep 18; 2026 Sep 18. PMID: 42755300.
- Per- and polyfluoroalkyl substances levels other than PFOS, PFOA, or PFHxS and liver cancer risk: a nested case-control analysis.Watling CZ, Petrick JL, Graubard BI, Hong HG, Zhang X, Barnett MJ, Barnard ME, Chen Y, Heather Eliassen A, Gaziano JM, Huang WY, Kang JH, Koshiol J, Lee IM, Loftfield E, Moore SC, Mucci LA, Neuhouser ML, Newton CC, Sesso HD, Shrubsole M, Sinha R, Tinker L, Triplette M, Um CY, Visvanathan K, Wactawski-Wende J, Watts EL, Willett WC, Wu F, Zheng W, Campbell PT, Hofmann JN, Purdue MP, Barupal D, McGlynn KA. J Natl Cancer Inst. 2026 Sep 17; 2026 Sep 17. PMID: 42752878.
- Menopausal hormone therapy and primary liver cancer: long-term follow-up of the women's health initiative randomized trials.Pichardo MS, Aragaki AK, Manson JE, Pan K, Jung SY, Rohan TE, Mszar R, Chlebowski RT. Br J Cancer. 2026 Sep 16; 2026 Sep 16. PMID: 42749856.
- ALDH2 Deficiency Promotes Mammary Epithelial Stemness and Proliferative Morphogenesis Through Oxidative Stress, RANKL Induction, and Estrogen Receptor Signaling.Ma Z, Parris AB, Lester M, Gissendanner D, Vasiliou V, Yang X. Cells. 2026 Sep 9; 2026 Sep 9. PMID: 42782735.
- Frailty and low utilization of curative-intent surgical resection in nonmetastatic pancreatic cancer.Raymond-King L, McGrath S, Mukherjee B, Wang Y, Parikh H, Rothen J, Soulos PR, Gross CP, Kunstman JW. JNCI Cancer Spectr. 2026 Sep 3. PMID: 42536427.
- Interplay of gut microbiota, immune cells and natural products in reshaping cancer immunotherapy.Wu X, Lu L, Li T, Zhao L, Wang L, Yao Y, Chen J, Liu T, Li X, Zhu X, Ma Q, Li X, Zhu G. Front Microbiol. 2026; 2026 Sep 1. PMID: 42745936.
- Multilevel Network Meta-Regression With a Survival Outcome and an Application to Non-Small Cell Lung Cancer.Jia R, Yi H, Teng Z, Tang S, Wang J, Ma S. Stat Med. 2026 Sep. PMID: 42687434.
- Matched targeted therapy use after broad genomic profiling in advanced Non-Small cell lung cancer.Wang X, Long JB, Rothen J, Aremu AO, Huang S, Soulos PR, Robinson TJ, Presley CJ, Goldberg SB, Mamtani R, Wang SY, Ma S, Dinan MA, Gross CP. J Natl Cancer Inst. 2026 Sep 1; 2026 Sep 1. PMID: 42679379.
- Association of GLP-1 receptor agonists, SGLT 2 inhibitors, DPP-4 inhibitors, and sulfonylureas with incident cancer in type 2 diabetes.Sklepinski SM, Herrin J, Swarna KS, Neumiller JJ, Galindo RJ, Umpierrez GE, Ross JS, Deng Y, Polley EC, Mickelson MM, McCoy RG. Diabetes Res Clin Pract. 2026 Sep; 2026 Aug 17. PMID: 42607727.
- The Role of Gastric Atrophy in the Association between Helicobacter pylori Infection and Esophageal Adenocarcinoma.Zhang J, Bellocco R, Jia Y, Nasrollahzadeh D, Zagai U, Jeske R, Waterboer T, Wu AH, Anderson LA, Risch HA, Vaughan TL, Ye W. Cancer Epidemiol Biomarkers Prev. 2026 Sep 1. PMID: 42274332.
- Blood-based proteomic profiling reveals context-dependent changes in BCL2-associated signaling during taxane therapy in breast cancer patients.Munshani S, Ibrahim EY, Rodwin RL, Ferrucci LM, Blenman K, Lustberg M, Ehrlich BE. FEBS Open Bio. 2026 Sep; 2026 Mar 26. PMID: 41883148.
- Interprovider Variation in Initiation of Bone-Modifying Agents for Patients With Prostate Cancer.Mitchell AP, Salner A, Palyca P, Farooki A, Persaud S, Chakraborty N, Bhamidipati D, Klimchuk M, Dinan MA, Leapman MS, Lipitz-Snyderman A, Hamid A, Ostroff JS, Morris MJ. JCO Oncol Pract. 2026 Sep; 2025 Nov 3. PMID: 41183247.
- Association between genomic classifier scores and initial management of localized prostate cancer in the United States.Leapman MS, Wang R, Sprenkle PC, Kim IY, Loeb S, Seibert TM, Cooperberg MR, Gann PH, Ginsburg K, Catalona WJ, Dinan MA, Gross CP, Ma X. J Natl Cancer Inst. 2026 Aug 31; 2026 Aug 31. PMID: 42671337.
- Driver mutation impact in Chinese hepatocellular carcinoma.Wu R, Xing H, Townsend JP. PLoS One. 2026; 2026 Aug 24. PMID: 42636226.
- Not always towards the null: reconsidering the direction of overadjustment bias.Smit F, Boroumand F, Tennant PWG, Mallitt KA, Chiolero A, van Zwieten A, Khalatbari-Soltani S. Int J Epidemiol. 2026 Aug 18. PMID: 42821507.
- Protocol for a Sequential Multiple Assignment Randomized Trial to Improve Physical Activity and Diet Quality in Survivors of Cancer.Chow E, Lee E, Hershberger M, Jenssen K, Di C, Doody D, Hogue B, Mendoza J, Muller T, Schenk J, Syrjala K, Xu Y, Yi J, Zhao YQ, Armstrong G, Neuhouser M, Oeffinger K. JMIR Res Protoc. 2026 Aug 13; 2026 Aug 13. PMID: 42594273.
- Commercial price variation in precision oncology testing across US hospitals.Mooghali M, Skydel JJ, Gross CP, Dusetzina SB, Walther Z, Lustberg M, Ross JS, Wallach JD. Health Aff Sch. 2026 Aug; 2026 Aug 6. PMID: 42626283.
- Why Americans are Dying Younger? NIH Is Not the Problem. Our Broken Healthcare Delivery Is.Ignacio RB, Pagkas-Bather J, Gonsalves G, Gianella S. J Infect Dis. 2026 Aug 3. PMID: 41420662.
- The Great Escape: the systems biology of endocrine resistance and lineage plasticity.Dragnev CPC, Fu Z, Huang S, Perry CJ, Kahn A, Dinan MA, Shen Tan W, Leapman M, Braun DA, Warrick J, Beltran H, Mu P. Endocr Relat Cancer. 2026 Aug 1. PMID: 42573111.
- All-Cause and Disease-Specific Mortality Among U.S. Adults Living With Co-Existing Cancer and Atherosclerotic Cardiovascular Disease.Mszar R, Ferrucci LM, Satti DI, Spatz ES, Parekh T, Baldassarre LA, Hull SC, Cartmel B, Irwin ML, Clasen SC. JACC Adv. 2026 Aug; 2026 Jul 20. PMID: 42475820.
- Potential Benefits and Harms of Screening Strategies for Monoclonal Gammopathy of Undetermined Significance in the US: A Simulation Study.Ahmad I, Wang R, Neparidze N, Lange J, Wang SY. Clin Lymphoma Myeloma Leuk. 2026 Aug; 2026 Jun 9. PMID: 42392944.
- Performance of Lung Cancer Risk Prediction Models in Different Racial and Ethnic Groups in the United States: Results From the Lung Cancer Cohort Consortium.Feng X, Guida F, Guenoun A, Alcala K, Aldrich MC, Arslan AA, Cai Q, Zheng W, Chen C, Triplette M, Tinker LF, Patel AV, Liao LM, Sinha R, Rohan TE, Sesso HD, Zhang X, Visvanathan K, Wang Y, Johansson M, Robbins HA. Ann Intern Med. 2026 Aug; 2026 Jun 30. PMID: 42372272.
- Why Americans are Dying Younger? NIH Is Not the Problem. Our Broken Healthcare Delivery Is.Ignacio RB, Pagkas-Bather J, Gonsalves G, Gianella S. Clin Infect Dis. 2026 Jul 23. PMID: 41420651.
- Estimating the Quality-Adjusted Life-Year Loss due to Fatal and Nonfatal COVID-19 Outcomes across US States and Counties, July 2020 to December 2022.Mikdashi F, Murray-Watson RE, Lopes R, Bilinski A, Yaesoubi R. MDM Policy Pract. 2026 Jul-Dec; 2026 Jul 21. PMID: 42488798.
- Obesity phenotypes, omics signatures, and risk of adverse liver outcomes.Zhao L, Chen Y, Li J, Wang C, Taddei TH, Ma X, Ma S, Demler O, Yazdani A, Osifala O, Urbistondo DM, Martínez-González MA, Tobias DK, Giovannucci E, Sesso HD, Manson JE, Hu F, Zhang X. J Natl Cancer Inst. 2026 Jul 21; 2026 Jul 21. PMID: 42482169.
- Evaluating the prognostic value of mutational signatures in small-cell lung cancer through reference-based signature assignment and continuous activity analysis.Garg R, Glasmacher KA, Augert A, Townsend JP. Front Genet. 2026; 2026 Jul 20. PMID: 42544366.
- Gene-Temperature Interactions and Risk of Childhood Acute Lymphoblastic Leukemia.Rogne T, Wang R, Wang P, Chen K, Ma S, Warren JL, Metayer C, Wiemels JL, DeWan AT, Ma X. medRxiv. 2026 Jul 10; 2026 Jul 10. PMID: 42465884.
- Circulating pre-diagnostic metabolites and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a population-based study of 12 cohorts.Watling CZ, Watts EL, Loftfield E, Graubard BI, Hong HG, Zhang X, Barnett MJ, Buring JE, Barnard ME, Chen Y, Eliassen AH, Gaziano JM, Hofmann JN, Huang WY, Kang JH, Koshiol J, Lee IM, Moore SC, Mucci LA, Neuhouser ML, Newton CC, Purdue MP, Sesso HD, Shrubsole M, Sinha R, Tinker L, Triplette M, Um CY, Visvanathan K, Wactawski-Wende J, Willett WC, Wu F, Zheng W, Campbell PT, Barupal D, Petrick JL, Mcglynn KA. J Natl Cancer Inst. 2026 Jul 10; 2026 Jul 10. PMID: 42429571.
- Tumor characteristics associated with tomosynthesis versus digital mammography in older women with screen-detected breast cancer.Huang S, Westvold SJ, Soulos PR, Lewin JM, Zhan H, Lustberg MB, Greenup RA, Richman IB, Winer EP, Robinson TJ, Dinan MA. Breast Cancer Res Treat. 2026 Jul 8; 2026 Jul 8. PMID: 42420682.
- Community-Based Helicobacter pylori Screening to Identify Gastric Cancer Risk Among Korean-Born Adults in the United States.Hyun CS, Hong SH, Zhang X, Shin JI, Kim SS, Laine L. Public Health Rep. 2026 Jul 6; 2026 Jul 6. PMID: 42405769.
- Development of a Biology-Informed Chemical Mixture Index for Oxidative Stress and Mortality in NHANES 2005-2010: A Survey-Weighted Quantile G-Computation Approach.Rodríguez-Carmona Y, Bakulski KM, Walker E, Wang X, Hao W, Mukherjee B, Park SK. medRxiv. 2026 Jul 2; 2026 Jul 2. PMID: 42428090.
- Demographic, birth, parental characteristics, and the risk of early-onset colorectal cancer: A population-based nested case-control study in California.Siddique S, Wang R, Berardi D, Johnson CH, Wiemels JL, Metayer C, Ma X. Cancer. 2026 Jul 1. PMID: 42324895.
- Adherence to pro-vegetarian dietary patterns and gastric cancer risk: a pooled analysis of the StoP Consortium.Oncina-Cánovas A, Torres-Collado L, García-de-la-Hera M, González-Palacios S, Ojeda-Belokon C, Negri E, Pelucchi C, Lagiou A, Lagiou P, Lunet N, Morais S, Martin V, Castaño-Vinyals G, López-Carrillo L, Hernández-Ramírez RU, Camargo MC, Curado MP, Zhang ZF, La Vecchia C, Boffetta P, Vioque J. Gastric Cancer. 2026 Jul; 2026 May 14. PMID: 42133181.
- Prostate-Specific Membrane Antigen Imaging and Initial Treatment for Prostate Cancer.Leapman MS, Rothen J, Long JB, Kim IE, Mitchell AP, Yu JB, Dinan MA, Gross CP, Ma X. JAMA Oncol. 2026 Jul 1. PMID: 42096231.
- School-based exposures to oil and gas development for public school children in the United States.Clark CJ, Campbell E, Grady ST, Buonocore J, Aker A, Deziel NC, Casey JA, Willis M. J Expo Sci Environ Epidemiol. 2026 Jul; 2026 Mar 28. PMID: 41904266.
- Consumption of whole and refined grains and the risk of gastric cancer: a pooled analysis within the Stomach cancer Pooling (StoP) Project.Turati F, Bravi F, Pelucchi C, Bonzi R, Johnson KC, Hu J, Ferraroni M, Zhang ZF, Yu G, Lunet N, Morais S, Zaridze D, Maximovitch D, Vioque J, Gonzalez-Palacios S, Curado MP, Dias-Neto E, Castaño-Vinyals G, Fernández de Larrea-Baz N, López-Carrillo L, Hernández-Ramirez RU, Tsugane S, Hamada GS, Ward MH, Mu L, Rabkin CS, Hidaka A, Lagiou A, Lagiou P, López-Cervantes M, Boffetta P, Camargo MC, Boccia S, Negri E, La Vecchia C. Eur J Nutr. 2026 Jun 13; 2026 Jun 13. PMID: 42287468.
- Higher Noncardia Gastric Cancer Risk Occurs Earlier in Hispanic and Asian Populations.Hyun CS, Wang R. Gastro Hep Adv. 2026; 2026 Jun 10. PMID: 42571374.
- Moments of deep connection between clinicians and patients in oncology: a mixed-methods study of sacred moments.Yasin F, Puklin L, Quinn M, Norman K, Saint S, Sanft T. Front Psychol. 2026; 2026 Jun 9. PMID: 42344987.
- Decreases in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers: HPV-IMPACT, 2008 to 2019.Stefanos R, Gargano JW, Niccolai LM, Castilho JL, Park IU, Bostick EA, Ehlers S, Blankenship S, Brackney MM, Chan K, Kurtz R, Whitney E, Moritz RE, Vigar MK, Querec TD, Unger ER, Markowitz LE. Cancer Epidemiol Biomarkers Prev. 2026 Jun 2. PMID: 42089801.
- Community perspectives on the return of research results and ownership of data and specimens for brain tumor genomic research.Kwan BM, Barnard JG, Ritger C, Staton EW, Perkins I, Gonzalez-Fisher R, Lennox LA, Gay N, Johnson KC, Verhaak RGW, Claus EB, DeCamp M, Salmi L. SSM Qual Res Health. 2026 Jun; 2026 Mar 11. PMID: 42389225.
- Artificially Sweetened and Sugar-Sweetened Beverage Intake and Risk of Liver Cancer.Watling CZ, Zhao L, Zhang X, Deubler E, Gonzalez-Feliciano AG, Graubard BI, Petrick JL, Wojt A, Butera G, Hofmann JN, Beane Freeman LE, Shrubsole MJ, Zheng W, Sudenga SL, Schernhammer E, Eliassen AH, Mucci LA, Sesso HD, Sinha R, Loftfield E, Um CY, McCullough ML, Jenab M, Zhang X, McGlynn KA. JAMA Netw Open. 2026 Jun 1; 2026 Jun 1. PMID: 42268607.
- RETRACTED: Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort.Hulscher N, Victory K, Thorp JA, Pinsky D, Diaz-Villalobos A, Gillooly P, Coulson F, Annazone M, Radesi C, Brooks J, McCullough PA, Risch H. Anticancer Res. 2026 Jun. PMID: 42203321.
- Long-read nanopore shotgun metagenomic DNA sequencing for river biodiversity, wildlife, pollution, and environmental health monitoring.Nousias O, Duffy FG, Duffy IJ, McCauley M, Whilde J, Duffy DJ. NAR Genom Bioinform. 2026 Jun; 2026 Apr 24. PMID: 42038409.
- Dyspepsia Care as a Missed Gateway to Gastric Cancer Prevention in High-Risk U.S. Populations.Hyun C, Oh SS, Hong SH, Kumar S, Shin JI. J Immigr Minor Health. 2026 Jun; 2026 Feb 23. PMID: 41729425.
- Changes in Use, Cost, and Value of Breast Cancer Screening Among Older Women in the US.Richman I, Long JB, Lindsay ME, Fendrick AM, Kyanko K, Gross CP. J Gen Intern Med. 2026 Jun; 2025 Sep 23. PMID: 40987968.
- Baseline predictors associated with successful weight loss among breast cancer survivors in the Lifestyle, Exercise, and Nutrition (LEAN) study.Hoobler R, Puklin LS, Harrigan M, Cartmel B, Li FY, Sanft T, Ferrucci LM, Irwin ML, Playdon MC. J Cancer Surviv. 2026 Jun; 2024 Nov 11. PMID: 39528779.
- Multi-ancestry transcriptome-wide association studies uncover insights into breast cancer genetics and biology.Ping J, Jia G, Cai Q, Guo X, Wang J, Tao R, Li B, Bauer JA, Xie Y, Ambs S, Barnard ME, Chen Y, Choi JY, Gao YT, Garcia-Closas M, Gu J, Hu JJ, Iwasaki M, John EM, Kweon SS, Li CI, Matsuda K, Matsuo K, Nathanson KL, Nemesure B, Olopade OI, Pal T, Park SK, Park B, Press MF, Sanderson M, Sandler DP, Yao S, Zheng Y, Ahearn T, Brewster AM, Falusi A, Hennis AJM, Ito H, Kubo M, Lee ES, Makumbi T, Mapoko BSE, Noh DY, O'Brien KM, Ojengbede O, Olshan AF, Park MH, Reid S, Yamaji T, Zirpoli G, Butler EN, Huang M, Low SK, Obafunwa J, Weinberg CR, Zhang H, Zhao H, Ambrosone CB, Cote ML, Huo D, Haiman CA, Kang D, Palmer JR, Troester MA, Shu XO, Long J, Zheng W. Nat Commun. 2026 May 30; 2026 May 30. PMID: 42218145.
- Migration-Informed Cancer Equity: A Global Perspective.Hyun CS. Ann Glob Health. 2026; 2026 May 26. PMID: 42221421.
- Management and outcomes of patients with liver cancer in China and the United States.Xu M, Geng Q, Shan T, Liu M, Chen J, Liu M, Han B, Xia C, Ran X, Sun K, Wang S, Shen Y, Chen R, Li L, Zhao H, Chen W, Lu L, Zhang Y, Zeng H. Chin Med J (Engl). 2026 May 20; 2026 Apr 1. PMID: 41922917.
- No-cost envelope modification improves fecal immunochemical test laboratory acceptance in a US Veterans Affairs colorectal cancer screening trial.Dominitz JA, Robertson DJ, Miller S, Beed A, Boardman K, Del Curto B, Gupta S, Imperiale TF, Larson MF, Lieberman DA, Rosa S, Shaukat A, Sultan S, Tapia D, Kyriakides TC. J Med Screen. 2026 May 19; 2026 May 19. PMID: 42154016.
- Risk of late recurrence of colorectal and breast cancer among older long-term cancer survivors.Yasin F, Westvold SJ, Long JB, Hyslop T, Cecchini M, Leeds I, Silber A, Wang SY, Spees L, Forman R, Kwaramba T, Taylor M, Gross CP, Dinan MA. JNCI Cancer Spectr. 2026 May 9. PMID: 41499446.
- Glycosite mapping and in situ mass spectrometry imaging of MUC2 glycopeptides via on-slide mucinase digestion.Lowery SC, Ribi MK, Chongsaritsinsuk J, Tran IP, Grimsley G, Stubler R, Mahoney KE, Lucas TM, Charkoftaki G, Santos-Neto A, Varki N, Vasiliou V, Angelo M, Drake RR, Malaker SA. Nat Commun. 2026 May 7; 2026 May 7. PMID: 42098121.
- AI-driven integration of genomic and exposome data for cancer risk: the combined risk score (CRS).Sarigiannis D, Boukovinas I, Kaparelou M, Dimopoulos AM, Psaltopoulou T, Pienta KJ, Anesti O, Karakitsios S. Hum Genomics. 2026 May 4; 2026 May 4. PMID: 42083001.
- Lipophilic Statins Deplete GPX4 to Promote Ferroptosis and Sensitize Cancer Cells to Immune Checkpoint Blockade.Talty R, Brooks VT, McGeary MK, Milette S, Zheng S, Flem-Karlsen K, Daniels A, Deshmukh M, Park K, Caraccio W, Yan H, Echeandia-Francis C, McNamara M, Hong S, Kirwin DS, Olino K, Johnson CH, Bosenberg M, Micevic G, Roy SF. Mol Cancer Ther. 2026 May 4. PMID: 41423587.
- Medicare Insurance Type and Broad Genomic Profiling in Metastatic Cancer.Chow RD, Rothen J, Long JB, Soulos PR, Wang X, Mamtani R, Ma S, Kunst N, Dinan MA, Gross CP. JAMA Netw Open. 2026 May 1; 2026 May 1. PMID: 42201732.
- Multi-ancestry genome-wide association and integrated multi-omics analyses of endometriosis and its clinical manifestations.Koller D, He J, Løkhammer S, Aranda S, Qiu D, Davtian D, Chen Q, Xu Z, Mao Z, Friligkou E, Karaca S, Cormand B, Flores I, Altmäe S, Mitjans M, Cabrera-Mendoza B, Polimanti R. Nat Genet. 2026 May; 2026 Apr 29. PMID: 42056605.
- Robust Heterogeneity Adjustment for Gaussian Graphical Model With Latent Variables.Li L, Li R, Ma S, Zhang Q. Stat Med. 2026 May. PMID: 42053355.
- Eligibility criteria for cancer drug trials in adult patients: Evidence from China, 2013-2021.Ma Z, Zhang Y, Chen D, Fu M, Han K, Zhang Y, Ross JS, Shi L, An Z, Guan X. Cancer. 2026 May 1. PMID: 42046201.
- Illustrating Implications of Misaligned Causal Questions and Statistics in Settings With Competing Events and Interest in Treatment Mechanisms.Kawahara T, McGrath S, Young JG. Stat Med. 2026 May. PMID: 42031001.
- Catabolism of extracellular glutathione supplies cysteine to support tumours.Hecht F, Zocchi M, Tuttle ET, Ward NP, Alimohammadi F, Khan AA, Gomes VC, Smith B, Twardowski JJ, Mills BN, Welle KA, Ghaemmaghami S, Zhou Z, Gan Y, Kang YP, Cazarin J, Soares ZG, Ozgurses ME, Zhao H, Sheehan C, Cognet G, Munger LD, Trivedi D, Asantewaa G, Blick-Nitko SK, Zoeller JJ, Chen Y, Vasiliou V, Turner BM, Mello SS, Altman BJ, Muir A, Coloff JL, Munger J, DeNicola GM, Harris IS. Nature. 2026 May; 2026 Mar 18. PMID: 41851454.
- Emerging biomarkers in melanoma: Bridging molecular discovery and precision oncology.Xu S, Huang Z, Li Y, Lu L, Ma W. Cancer Lett. 2026 May 1; 2026 Feb 22. PMID: 41734832.
- The impact of genetic and environmental risk factors on adverse liver outcomes.Zhang X, Zhao L, Campbell PT, Chen Y, Fang A, Liu Z, Li X, Yang W, Fan J, Petrick JL, McGlynn KA, Lai M, Zhang X. Int J Cancer. 2026 May 1; 2025 Dec 4. PMID: 41345374.
- Challenges in the return of molecular tumor profiling results.Lenz HJ, Craig DW, Johnson KC, Verhaak R, Bhattacharyya O, Davis B, Wesley C, Byron SA, Willman C, Kelley L, Claus EB, Trent J, Culver JO, Gray SW, Church AJ. J Natl Cancer Inst. 2026 May 1. PMID: 40929086.
- Mutational signature-based classification uncovers emerging oral cancer subtypes with distinct molecular patterns.Deneuve S, Fervers B, Bruno JS, Bach E, Senkin S, Goldman-Lévy G, Carreira C, Laklouk I, Hu R, Bouaoun L, Pérol O, Chavanel B, Lu L, Lozar T, Gheit T, Lambert PF, Coste I, Renno T, Zavadil J, Virard F. Int J Oral Sci. 2026 Apr 24; 2026 Apr 24. PMID: 42031720.
- Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals.Vergara C, Ni Z, Zhong J, McKean D, Connelly KE, Antwi SO, Arslan AA, Bracci PM, Du M, Gallinger S, Genkinger J, Haiman CA, Hassan M, Hung RJ, Huff C, Kooperberg C, Kastrinos F, LeMarchand L, Lee W, Lynch SM, Moore SC, Oberg AL, Park MA, Permuth JB, Risch HA, Scheet P, Schwartz A, Shu XO, Stolzenberg-Solomon RZ, Wolpin BM, Zheng W, Albanes D, Andreotti G, Bamlet WR, Beane-Freeman L, Berndt SI, Brennan P, Buring JE, Cabrera-Castro N, Campa D, Canzian F, Chanock SJ, Chen Y, Chung CC, Eliassen AH, Gaziano JM, Giles GG, Giovannucci EL, Goggins M, Goodman PJ, Hicks B, Hutchinson A, Jones MR, Katzke V, Kogevinas M, Kurtz RC, Laheru D, Lee IM, Malats N, Milne R, Mucci L, Neale RE, Orlow I, Patel AV, Peruchet L, Peters U, Porta M, Rabe KG, Real FX, Ricceri F, Rothman N, Sesso HD, Setiawan VW, Silverman D, Southey MC, Stampfer MJ, Tobias GS, Um C, Visvanathan K, Wactawski-Wende J, Wentzensen N, Willett WC, Yu H, Kraft P, Duggal P, Amundadottir LT, Klein AP. medRxiv. 2026 Apr 22; 2026 Apr 22. PMID: 42078392.
- Accelerating discovery of cancer causes for prevention in the era of rising early-onset cancers.Shi M, Patti GJ, Gunter MJ, Govindan R, Lansdorp-Vogelaar I, Wang T, Townsend JP, Colditz GA, Belkaid Y, Cao Y. Cell. 2026 Apr 16; 2026 Apr 7. PMID: 41997124.
- Exposure to nitrosatable drugs during pregnancy and childhood cancer: A cohort study in Taiwan.Deng C, Hu YH, Sirirungreung A, Chock EY, Liew Z, Ritz B, Lee PC, Heck JE. Int J Cancer. 2026 Apr 15; 2025 Nov 7. PMID: 41203947.
- Motivation to Participate in a Nutrition and Physical Activity Intervention During Chemotherapy for Breast Cancer: A Qualitative Study.Puklin LS, Harrigan M, McGowan C, Ferrucci LM, Cartmel B, Zupa M, Deyling M, Sanft T, Sharifi M, Irwin ML. Psychooncology. 2026 Apr. PMID: 42025931.
- Treatment Patterns Across Lines of Therapy for Advanced Non-Small Cell Lung Cancer in the United States.Lee DH, Li Y, Yang SC, Chiang AC, Soulos PR, Gross CP, Wang SY. Cancer Med. 2026 Apr. PMID: 42007970.
- Meta-Analysis of Median Survival Times With Inverse-Variance Weighting.McGrath S, Yang CH, Kimmelman J, Ozturk O, Steele R, Benedetti A. Stat Med. 2026 Apr. PMID: 41998861.
- GDF15 in the tumor microenvironment: A central mediator of cancer immunometabolism and therapeutic resistance.Lu L, Johnson CH, Khan SA, Irwin ML. Cytokine Growth Factor Rev. 2026 Apr; 2026 Jan 13. PMID: 41546893.
- Trends in Smoldering Myeloma Incidence in the United States From Cancer Registries, 2012-2022.Wang R, Davidoff AJ, Schoen M, Huber JH, Feuer EJ, Ruhl J, Neparidze N, Ma X, Chang SH, Wang SY. Am J Hematol. 2026 Apr; 2026 Jan 13. PMID: 41528052.
- Machine Learning Risk Stratification for Older Breast Cancer Survivors: Clinical Care Implications.Wheeler SB, Rotter J, Spees LP, Biddell CB, Trogdon JG, Alfano CM, Mayer DK, Dinan MA, Nekhlyudov L, Birken SA. Health Serv Res. 2026 Apr; 2025 Jul 16. PMID: 40671264.
- Update of the Methyltransferase Gene Family: Classification, Evolution and Biological Functions.Katsafadou AI, Falnes PØ, Bruford E, Braschi B, Hanson QM, Hall MD, Thompson DC, Nebert DW, Vasiliou V. Hum Genomics. 2026 Mar 25; 2026 Mar 25. PMID: 41882796.
- Global epidemiology of ovarian cancer: patterns, trends, and risk factors.Li R, Zhao A, Liu M, Lu L, Li B, Zeng H. Cancer Biol Med. 2026 Mar 24. PMID: 41877375.
- Glutathione is critical for NK cell-mediated immunity.Guerra L, Grusdat M, Kobayashi T, Longworth J, Kurniawan H, Franchina DG, Theodorakis G, Binsfeld C, Verschueren C, Bonetti L, Ewen A, Soriano-Baguet L, Alhamouieh S, Farinelle S, Dostert C, Chen Y, Vasiliou V, Vivier E, Lang PA, Brenner D. Cell Rep. 2026 Mar 24; 2026 Feb 23. PMID: 41734064.
- Cost-Effectiveness of Perioperative Durvalumab With Neoadjuvant Gemcitabine/Cisplatin in Muscle-Invasive Bladder Cancer Treatment.Su ZT, Florissi IS, Geller AE, Johnson Iii BA, Hoffman-Censits JH, Patel SH, Townsend JP, Hahn NM, Kates MR. J Natl Compr Canc Netw. 2026 Mar 19; 2026 Mar 19. PMID: 41911914.
- Impact of Clonal Hematopoiesis of Indeterminate Potential on Treatment Response and Tumor Microenvironment in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.Yang M, Yin G, Yu Y, Zhang D, Wang X, Zhou X, Liu X, Huang S, Shan Y, Liu X, Wang F, Wang J, Song Y, Wu Y, Liu DX, Yu Z, Xiang Y. J Mammary Gland Biol Neoplasia. 2026 Mar 5; 2026 Mar 5. PMID: 41781761.
- Germline Predisposition to Oncogenic Alkylating Damage in Colorectal Cancer.Gurjao C, Cazaubiel J, Tan C, Reardon B, Hofree M, Ugai T, Meyerhardt JA, Nowak JA, Giovannucci E, Townsend JP, Ogino S, Giannakis M. Cancer Epidemiol Biomarkers Prev. 2026 Mar 2. PMID: 41416871.
- Association of Family History and Polygenic Risk Scores With Prostate Cancer in Africa.Odole I, Andrews C, Agalliu I, Rohan T, Fernandez PW, Irusen H, Ntlaba SJ, Janivara R, Lachance J, Baichoo S, Mensah JE, Adjei AA, Abrahams AOD, Quarchie MN, Aisuodionoe-Shadrach OI, Nwegbu MM, Jamda MA, Oluwole PO, Chen WC, Joffe M, Adusei B, Doherty S, Pentz A, Adebiyi A, Ogunbiyi O, Jalloh M, Rebbeck TR. JCO Glob Oncol. 2026 Mar; 2026 Mar 11. PMID: 41812093.
- Competing subclones and fitness diversity shape tumor evolution across cancer types.Chen H, Shu J, Mudappathi R, Li E, Wang P, Bergsagel L, Yang P, Sun Z, Zhao L, Shi C, Townsend JP, Maley C, Liu L. Bioinformatics. 2026 Feb 28. PMID: 41826799.
- A Taxonomy for Assessing Real-World Targeted Cancer Therapy Options in the Context of Broad Genomic Profiling.Wang X, Long JB, Rothen J, Huang S, Soulos PR, Goldberg SB, Robinson TJ, Ma S, Mamtani R, Presley CJ, Wang SY, Kunst N, Gross CP, Dinan MA. J Natl Compr Canc Netw. 2026 Feb 9; 2026 Feb 9. PMID: 41698347.
Centers and other resources
- Yale Cancer Center (YCC)The Center provides the best approaches for the prevention, detection, diagnosis, and treatment of cancer.
- Yale Center for Analytical Sciences (YCAS)YCAS collaborative team provides expertise in the design, conduct, and analysis of health and health care studies, methodological development, and education and training.
- Yale-Griffin Prevention Research Center (PRC)The PRC works with community partners to develop and implement community-based approaches to prevent and control chronic diseases such as heart disease, diabetes, and cancer.